Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab

Blood

Volumn 99, Issue 4, 2002, Pages 1486-1488

  Goldberg, Stuart L ^a,b,c   Pecora, Andrew L ^a,b,c   Alter, Robert S ^a,b,c   Kroll, Mark S ^a,b,c   Rowley, Scott D ^a,b,c   Waintraub, Stanley E ^a,b,c   Imrit, Kavita ^a,b,c   Preti, Robert A ^a,b,c  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b CentraState Medical Center   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; RITUXIMAB;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; B LYMPHOCYTE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; IMMUNOTHERAPY; INFECTION RISK; JC VIRUS; MALE; NONHODGKIN LYMPHOMA; PNEUMONIA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELAPSE; RETINITIS; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0037082494     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.4.1486     Document Type: Article

References (28)

1. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
2. Infectious complications after CD34-selected autologous peripheral blood stem cell transplantation
3. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
4. Rituximab permits in-vivo purging and collection of tumor free stem cell products prior to autologous transplantation for B-cell non-Hodgkin's lymphoma
5. Polymaviruses
6. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
7. Progressive multifocal leukoencephalopathy in patients with human immunodeficiency virus
8. Cellular and humoral immune response in progressive multifocal leukoencephalopathy
9. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS
10. Progressive multifocal leukoencephalopathy in Hodgkin's disease
11. Alpha interferon therapy in a case of probable progressive multifocal leukoencephalopathy
12. Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: A clinicopathological review of 16 cases
13. Dizziness and confusion after bone marrow transplantation
14. Cytomegalovirus-induced T-cell proliferation and the development of progressive multifocal leukoencephalopathy following bone marrow transplantation
15. Macrophage association of polyomavirus in progressive multifocal leukoencephalopathy: An immunohistochemical and ultrastructural study. Case report
16. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia
17. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2
18. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alphainterferon
19. Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5)
20. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation
21. Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation
22. The eye in bone marrow transplantation, VI: Retinal complications
23. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications
24. + immunoselected and unselected peripheral blood progenitor cell transplantation: A case-control study
25. + enriched versus non-T cell depleted autologous peripheral blood stem cell transplantation
26. Characterization of a human B lymphocyte specific antigen
27. Adjuvant rituximab after autologous peripheral blood stem cell transplant results in delayed immune reconstitution with increase in infectious complications
28. Immune reconstitution after autologous CD34-positive selected peripheral blood stem cell transplantation combined with rituximab for refractory B-cell non-Hodgkin's lymphoma